EcoDrugPlus

Ensembl ID : ENSSLDG00000001824
Gene Symbol: -
Cross references: -
30 Possible Orthologues:

Ensembl ID : ENSSLDG00000016264
Gene Symbol: -
Cross references: -
62 Possible Orthologues:

Ensembl ID : ENSSLDG00000003996
Gene Symbol: -
Cross references: -
131 Possible Orthologues:

Ensembl ID : ENSSLDG00000003758
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSSLDG00000018593
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSSLDG00000003877
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSSLDG00000003895
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSSLDG00000003907
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSSLDG00000015536
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSSLDG00000003418
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSSLDG00000023904
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSSLDG00000006538
Gene Symbol: -
Cross references: -
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).